_MACHINE TRANSLATION_
The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer” or the “Company”) hereby publishes, as an attachment to this current report, the resolutions adopted by the Ordinary General Meeting of Shareholders (the “OGM”) held on 16 July 2026 following the adjournment announced on 23 June 2026 and subsequently extended on 7 July 2026, together with the voting results.
The draft resolutions submitted on 15 July 2026 by a shareholder representing at least one-twentieth of the Company’s share capital, namely TOTAL Closed-End Investment Fund (TOTAL Fundusz Inwestycyjny Zamknięty) (the “Shareholder”), pursuant to Article 401 § 4 of the Polish Commercial Companies Code, relating to items 17 and 18 of the agenda of the Issuer’s Ordinary General Meeting of Shareholders, were put to a vote. These draft resolutions were announced by the Issuer in ESPI Current Report No. 25/2026 dated 15 July 2026.
The following resolutions:
Resolution No. 21/06/2026 of the Ordinary General Meeting of BIOCELTIX Spółka Akcyjna with its registered office in Wrocław dated 16 July 2026 regarding the establishment of an Incentive Programme at the Company and the repeal of Resolution No. 05/02/2021 of the Extraordinary General Meeting dated 9 February 2021, as amended by Resolution No. 19/06/2024 of the Ordinary General Meeting dated 26 June 2024;
and
Resolution No. 22/06/2026 of the Ordinary General Meeting of BIOCELTIX Spółka Akcyjna with its registered office in Wrocław dated 16 July 2026 regarding the issue of Series A registered subscription warrants with the exclusion of pre-emptive rights of existing shareholders, the conditional increase of the Company’s share capital through the issue of Series H ordinary bearer shares with the exclusion of pre-emptive rights of existing shareholders, the repeal of Resolution No. 03/02/2021 and Resolution No. 04/02/2021 of the Extraordinary General Meeting dated 9 February 2021, and the related amendment to the Company’s Articles of Association,
were adopted in the wording submitted by the Shareholder.
Detailed legal basis: § 20(1)(6) of the Regulation of the Minister of Finance of 6 June 2025 on current and periodic information to be disclosed by issuers of securities and on conditions for recognizing as equivalent information required under the laws of a non-member state.
Attachment:
Text of the adopted resolutions.
20260716_ESPI_Raport_27_2026_Uchwały_Podjęte_ZWZ_Załącznik.docx
20260716_ESPI_Raport_27_2026_Uchwały_Podjęte_ZWZ_Załącznik.pdf
Signatures of persons representing the Company:
Łukasz Bzdzion – President of the Management Board
Paweł Wielgus – Member of the Management Board